# Treatment of Depression in Parkinson's Disease

> **NCT01416818** · PHASE2 · UNKNOWN · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 60 (estimated)

## Conditions studied

- Depression in Parkinson's Disease

## Interventions

- **DRUG:** Xiaoyao Pill
- **DRUG:** Bupleurum+Ginkgo
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01416818
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-05
- **Primary completion:** 2011-10
- **Final completion:** 2011-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2011-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01416818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01416818, "Treatment of Depression in Parkinson's Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01416818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*